Globus Medical (GMED) | Stock Overview & Key Data

Globus Medical Inc. | Healthcare

$61.25

5.93%

| Compare Stocks:

Globus Medical vs Abbott Laboratories Globus Medical vs Boston Scientific Globus Medical vs Masimo Globus Medical vs Bio-Rad Globus Medical vs Bio-Rad Laboratories Globus Medical vs S&P 500 | Market

Globus Medical Performance Comparison

Loading chart data...

Globus Medical

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $58.27 High: $61.33

on May 16, 2025

52 Week Range

Low: $54.48 High: $94.93

on May 9, 2025

on January 30, 2025

All-Time High: $94.93 on January 27, 2025

Key Statistics

Market Cap i $7.8B

EPS i 1.34

P/E Ratio (TTM) i 43.15

Forward P/E i 16.91

P/B Ratio i 1.91

PEG Ratio i 16.91

Div. Yield i 0.00%

ROE i 4.63%

Beta i 1.328

Debt to Equity i 2.27

Financial Highlights

Profitability

Gross Margin i 67.33%

Operating Margin i 16.40%

Profit Margin i 7.39%

Returns and Earnings

Return on Assets (TTM) i 5.90%

Return on Equity (TTM) i 4.63%

EBITDA i $610.0M

Net Income (TTM) i $185.6M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Globus Medical GMED	7.83B Mid-cap	9.73%	-13.90%	-27.80%	-25.15%	-25.15%	-4.86%	-5.62%	11.18%
Abbott Laboratories ABT	232.01B Mega-cap	1.16%	3.92%	3.53%	14.84%	18.81%	29.48%	19.02%	47.35%
Boston Scientific BSX	155.14B Large-cap	3.08%	11.32%	0.65%	17.22%	18.63%	42.04%	170.35%	195.27%
Masimo MASI	8.37B Mid-cap	-0.72%	2.49%	-13.81%	-3.35%	-7.78%	25.22%	10.03%	-37.00%
Bio-Rad BIO.B	7.01B Mid-cap	6.68%	11.00%	-19.86%	-25.32%	-23.19%	-10.66%	-50.48%	-46.37%
Bio-Rad Laboratories BIO	6.57B Mid-cap	4.19%	1.41%	-12.20%	-20.59%	-23.76%	-15.41%	-52.40%	-47.39%

Ownership & Short Interest

Insider Ownership i 0.69%

Institutional Ownership i 103.50%

Shares Short i 4M

Short Ratio i 3.80

Short % of Shares Outstanding i 4.18%

Average 10-Day Volume i 3M

Average 90-Day Volume i 2M

Globus Medical Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Globus Medical would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is GMED's 52-week high and low?

In the last 52 weeks, Globus Medical reached a high of $94.93 (on January 30, 2025) and a low of $54.48 (on May 9, 2025).

What is the market cap and P/E ratio for GMED?

Curious about Globus Medical's size and valuation? Its market capitalization stands at 7.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 43.15, and the forward P/E (looking ahead) is 16.91.

Does GMED pay dividends? If so, what's the yield?

As for dividends, Globus Medical isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Globus Medical's main competitors or similar companies to consider before investing?

When looking at Globus Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Abbott Laboratories ABT	232.01B	Healthcare	Medical Devices	29.48%	19.02%
Boston Scientific BSX	155.14B	Healthcare	Medical Devices	42.04%	170.35%
Masimo MASI	8.37B	Healthcare	Medical Devices	25.22%	10.03%
Bio-Rad BIO.B	7.01B	Healthcare	Medical Devices	-10.66%	-50.48%
Bio-Rad Laboratories BIO	6.57B	Healthcare	Medical Devices	-15.41%	-52.40%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Globus Medical Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Globus Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.63%, the Debt to Equity ratio from the most recent quarter is 2.27, and its Gross Profit Margin stands at 67.33%.

What is the recent revenue and earnings growth for GMED?

Looking at Globus Medical's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.40%, and quarterly earnings saw a YoY growth of N/A.

How much of GMED stock is held by insiders and institutions?

Wondering who owns Globus Medical stock? Company insiders (like executives and directors) hold about 0.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 103.50%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.